These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 34332706)

  • 21. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
    Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
    BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list.
    Maraj D; Steiner L; Persaud N
    J Clin Tuberc Other Mycobact Dis; 2022 May; 27():100305. PubMed ID: 35308809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Availability of Access, Watch, and Reserve groups of essential antibiotics: a cross-sectional survey.
    Rafi S; Anjum SM; Usman M; Nawaz HA; Chaudhry M; Babar ZU; Rasheed H
    Front Public Health; 2023; 11():1251434. PubMed ID: 38239798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis.
    Sulis G; Sayood S; Katukoori S; Bollam N; George I; Yaeger LH; Chavez MA; Tetteh E; Yarrabelli S; Pulcini C; Harbarth S; Mertz D; Sharland M; Moja L; Huttner B; Gandra S
    Clin Microbiol Infect; 2022 Sep; 28(9):1193-1202. PubMed ID: 35339675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Antibiotic Use in Kazakhstan for the Period 2017-2019 Based on WHO Access, Watch and Reserve Classification (AWaRe 2019).
    Zhussupova G; Utepova D; Orazova G; Zhaldybayeva S; Skvirskaya G; Tossekbayev K
    Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33430122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Not recommended fixed-dose antibiotic combinations in low- and middle-income countries - the example of Tanzania.
    Vliegenthart-Jongbloed K; Jacobs J
    Antimicrob Resist Infect Control; 2023 Apr; 12(1):37. PubMed ID: 37076936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of essential medicines lists in 137 countries.
    Persaud N; Jiang M; Shaikh R; Bali A; Oronsaye E; Woods H; Drozdzal G; Rajakulasingam Y; Maraj D; Wadhawan S; Umali N; Wang R; McCall M; Aronson JK; Plüddemann A; Moja L; Magrini N; Heneghan C
    Bull World Health Organ; 2019 Jun; 97(6):394-404C. PubMed ID: 31210677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic use prior to seeking medical care in patients with persistent fever: a cross-sectional study in four low- and middle-income countries.
    Ingelbeen B; Koirala KD; Verdonck K; Barbé B; Mukendi D; Thong P; El Safi S; Van Duffel L; Bottieau E; van der Sande MAB; Boelaert M; Chappuis F; Jacobs J
    Clin Microbiol Infect; 2021 Sep; 27(9):1293-1300. PubMed ID: 33188934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic antibiotic sales and WHO recommendations, India.
    Mehta A; Brhlikova P; McGettigan P; Pollock AM; Roderick P; Farooqui HH
    Bull World Health Organ; 2022 Oct; 100(10):610-619. PubMed ID: 36188020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The WHO essential medicines list AWaRe book: from a list to a quality improvement system.
    Sharland M; Zanichelli V; Ombajo LA; Bazira J; Cappello B; Chitatanga R; Chuki P; Gandra S; Getahun H; Harbarth S; Loeb M; Mendelson M; Moja L; Pulcini C; Sati H; Tacconelli E; Zeng M; Huttner B
    Clin Microbiol Infect; 2022 Dec; 28(12):1533-1535. PubMed ID: 36007869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
    Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
    Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reporting on antibiotic use patterns using the WHO Access, Watch, Reserve classification in the Caribbean.
    Rocke T; El Omeiri N; Quiros RE; Hsieh J; Ramon-Pardo P
    Rev Panam Salud Publica; 2022; 46():e186. PubMed ID: 36382253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawn medicines included in the essential medicines lists of 136 countries.
    Charles O; Onakpoya I; Benipal S; Woods H; Bali A; Aronson JK; Heneghan C; Persaud N
    PLoS One; 2019; 14(12):e0225429. PubMed ID: 31791048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.
    Bazargani YT; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
    PLoS One; 2014; 9(9):e106072. PubMed ID: 25259517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in the hospital-sector consumption of the WHO AWaRe Reserve group antibiotics in EU/EEA countries and the United Kingdom, 2010 to 2018.
    Benkő R; Matuz M; Pető Z; Weist K; Heuer O; Vlahović-Palčevski V; Monnet DL; Galistiani GF; Blix HS; Soós G; Hajdú E; ;
    Euro Surveill; 2022 Oct; 27(41):. PubMed ID: 36239173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric pharmacokinetics of the antibiotics in the access and watch groups of the 2019 WHO model list of essential medicines for children: a systematic review.
    Rashed AN; Jackson C; Gastine S; Hsia Y; Bielicki J; Standing JF; Tomlin S; Sharland M
    Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1099-1106. PubMed ID: 31760892
    [No Abstract]   [Full Text] [Related]  

  • 37. AWaRe classification of antibiotics prescribed within 2018-2021 for hospitalised medical and surgical patients in Uyo, Nigeria.
    Ekuma A; Onukak A; Udoette S; Versporten A; Pauwels I; Oduyebo O; Goossens H
    Pan Afr Med J; 2023; 46():80. PubMed ID: 38282765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric Antibiotic Prescribing in China According to the 2019 World Health Organization Access, Watch, and Reserve (AWaRe) Antibiotic Categories.
    Wang CN; Huttner BD; Magrini N; Cheng Y; Tong J; Li S; Wan C; Zhu Q; Zhao S; Zhuo Z; Lin D; Yi B; Shan Q; Long M; Jia C; Zhao D; Sun X; Liu J; Zhou Y; Li R; Liu J; Zhu Y; Miao R; Zhu C; Qi Z; Wang C; Wu S; Xu X; Zhou L; Ye W; Luo N; Gao H; Yang P; Bieerding M; Tang J; Zeng M;
    J Pediatr; 2020 May; 220():125-131.e5. PubMed ID: 32093934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ground level utility of Access, Watch, Reserve classification: Insights from a tertiary care center in North India.
    Negi G; Kb A; Panda PK
    World J Exp Med; 2023 Dec; 13(5):123-133. PubMed ID: 38173545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential medicines for breast cancer in low and middle income countries.
    Bazargani YT; de Boer A; Schellens JH; Leufkens HG; Mantel-Teeuwisse AK
    BMC Cancer; 2015 Aug; 15():591. PubMed ID: 26283654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.